Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy.
EMBL, Grenoble, France.
J Exp Clin Cancer Res. 2023 Jul 29;42(1):189. doi: 10.1186/s13046-023-02752-8.
The 5th Workshop IRE on Translational Oncology was held in Rome (Italy) on 27-28 March at the IRCCS Regina Elena National Cancer Institute. This meeting entitled "The New World of RNA diagnostics and therapeutics" highlightes the significant progress in the RNA field made over the last years. Research moved from pure discovery towards the development of diagnostic biomarkers or RNA-base targeted therapies seeking validation in several clinical trials. Non-coding RNAs in particular have been the focus of this workshop due to their unique properties that make them attractive tools for the diagnosis and therapy of cancer.This report collected the presentations of many scientists from different institutions that discussed recent oncology research providing an excellent overview and representative examples for each possible application of RNA as biomarker, for therapy or to increase the number of patients that can benefit from precision oncology treatment.In particular, the meeting specifically emphasized two key features of RNA applications: RNA diagnostic (Blandino, Palcau, Sestito, Díaz Méndez, Cappelletto, Pulito, Monteonofrio, Calin, Sozzi, Cheong) and RNA therapeutics (Dinami, Marcia, Anastasiadou, Ryan, Fattore, Regazzo, Loria, Aharonov).
第五届转化肿瘤学IRE 研讨会于 3 月 27 日至 28 日在罗马(意大利)的 IRCCS Regina Elena 国家癌症研究所举行。本次会议题为“RNA 诊断和治疗的新世界”,重点介绍了近年来 RNA 领域取得的重大进展。研究从纯粹的发现转向开发诊断生物标志物或针对 RNA 的靶向治疗方法,并在多项临床试验中寻求验证。非编码 RNA 尤其成为本次研讨会的焦点,因为它们具有独特的特性,使其成为癌症诊断和治疗的有吸引力的工具。本报告汇集了来自不同机构的许多科学家的演讲,讨论了最近的肿瘤学研究,为 RNA 作为生物标志物、治疗或增加受益于精准肿瘤学治疗的患者数量的每种可能应用提供了出色的概述和代表性示例。特别是,会议特别强调了 RNA 应用的两个关键特征:RNA 诊断(Blandino、Palcau、Sestito、Díaz Méndez、Cappelletto、Pulito、Monteonofrio、Calin、Sozzi、Cheong)和 RNA 治疗(Dinami、Marcia、Anastasiadou、Ryan、Fattore、Regazzo、Loria、Aharonov)。